Pharma4ever A/S — Credit Rating and Financial Key Figures
CVR number: 36436573
Hørkær 24, 2730 Herlev
www.pharma4ever.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 8 802.01 | 8 945.62 | 13 009.83 | 15 279.18 | 15 475.54 |
| Employee benefit expenses | -6 480.28 | -6 710.61 | -9 564.85 | -10 203.49 | -12 367.59 |
| Total depreciation | -30.27 | -40.88 | -24.84 | -0.48 | |
| EBIT | 2 291.46 | 2 194.14 | 3 420.13 | 5 075.22 | 3 107.95 |
| Other financial income | 0.07 | 10.17 | 2.80 | 5.61 | |
| Other financial expenses | -12.65 | -13.20 | -12.28 | -5.50 | -11.10 |
| Pre-tax profit | 2 278.88 | 2 191.11 | 3 407.86 | 5 072.52 | 3 102.46 |
| Income taxes | - 502.04 | - 484.74 | - 752.78 | -1 128.75 | - 686.25 |
| Net earnings | 1 776.84 | 1 706.37 | 2 655.08 | 3 943.77 | 2 416.21 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 148.53 | 107.65 | 0.48 | ||
| Tangible assets total | 148.53 | 107.65 | 0.48 | ||
| Investments total | 101.40 | ||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 1 701.76 | 3 560.71 | 4 974.19 | 7 795.37 | 7 332.42 |
| Prepayments and accrued income | 86.42 | 27.00 | |||
| Current other receivables | 725.82 | 11.63 | 609.04 | 34.65 | 34.65 |
| Current deferred tax assets | 117.00 | 85.54 | 133.79 | ||
| Short term receivables total | 2 544.57 | 3 657.88 | 5 669.66 | 7 857.01 | 7 500.85 |
| Cash and bank deposits | 1 910.40 | 1 109.25 | 580.45 | 1 921.88 | 1 159.39 |
| Cash and cash equivalents | 1 910.40 | 1 109.25 | 580.45 | 1 921.88 | 1 159.39 |
| Balance sheet total (assets) | 4 603.49 | 4 874.79 | 6 250.59 | 9 778.89 | 8 761.64 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 500.00 | 500.00 | 500.00 | 500.00 | 500.00 |
| Shares repurchased | 1 000.00 | 1 750.00 | 2 650.00 | 4 028.31 | 2 416.21 |
| Retained earnings | -1 653.75 | -1 626.91 | -2 570.54 | -3 943.77 | -2 416.21 |
| Profit of the financial year | 1 776.84 | 1 706.37 | 2 655.08 | 3 943.77 | 2 416.21 |
| Shareholders equity total | 1 623.09 | 2 329.46 | 3 234.54 | 4 528.31 | 2 916.21 |
| Provisions | 3.58 | 1.86 | 4.69 | 5.94 | |
| Non-current other liabilities | 345.80 | ||||
| Non-current liabilities total | 345.80 | ||||
| Current trade creditors | 255.79 | 1 078.36 | 1 123.47 | 3 097.27 | 3 563.90 |
| Short-term deferred tax liabilities | 111.96 | 17.50 | |||
| Other non-interest bearing current liabilities | 2 375.23 | 1 465.11 | 1 775.93 | 2 129.88 | 2 281.52 |
| Current liabilities total | 2 631.01 | 2 543.46 | 3 011.36 | 5 244.64 | 5 845.43 |
| Balance sheet total (liabilities) | 4 603.49 | 4 874.79 | 6 250.59 | 9 778.89 | 8 761.64 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.